Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
News | Peripheral Artery Disease (PAD)
Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
Out-of-hospital cardiac arrests (OCHA) cause significant mortality and morbidity, and the study is one the largest trials ever conducted on cardiac arrest patients admitted to intensive care units (ICU).
News | Cardiovascular Clinical Studies
New Data from Global TAME Study Supports Current Management of CO2 Levels in Cardiac Arrest Patients

June 16, 2023 — A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found ...

Home June 16, 2023
Home
News | Cardiovascular Clinical Studies
Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023

June 16, 2023 — Esperion presented results from an analysis comparing the cardiovascular risk reduction benefits of ...

Home June 16, 2023
Home
Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
News | Cardiac Imaging
Dr. Jonathan Weinsaft Named Chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and ...

Home June 15, 2023
Home
Kandu Health is working to fulfill an urgent need in healthcare by supporting stroke patients beyond the hospital through a team of clinically licensed navigators, community support groups, and an easy-to-use app.
News | Cardiovascular Clinical Studies
Kandu Health Achieves Successful Enrollment of the First 50 Stroke Survivors in its Stroke Recovery Program, Appoints New Leadership

June 15, 2023 — Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and ...

Home June 15, 2023
Home
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
News | Peripheral Artery Disease (PAD)
Endologix Receives FDA Approval of the DETOUR System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain.
News | Coronavirus (COVID-19)
New Imaging Technique Captures COVID-19’s Impact on the Brain

June 14, 2023 — A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies ...

Home June 14, 2023
Home
NIH-supported study could lead to less restrictions for those with hypertrophic cardiomyopathy
News | Cardiovascular Clinical Studies
Vigorous Exercise Not Tied to Increased Risk of Adverse Events in Rare Heart Condition

June 14, 2023 — Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for ...

Home June 14, 2023
Home
The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries
News | Stroke
Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program

June 14, 2023 — Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ...

Home June 14, 2023
Home
Novel polymeric valve aims to reduce re-operations and re-interventions
News | Pediatric Cardiology
PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial

June 13, 2023 — PECA Labs, a medical device company reimagining vascular grafts and valves with durable polymeric ...

Home June 13, 2023
Home
The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease
News | Stents
Gore Initiates Study to Compare the Gore Viabahn VBX Balloon Expandable Endoprosthesis to Bare Metal Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
In combination with BIOTRONIK Home Monitoring the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden
News | Remote Monitoring
REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients

June 13, 2023 — A recent study highlights that implantable cardioverter-defibrillator (ICD) patients with new-onset ...

Home June 13, 2023
Home
Rapid adoption of wireless cardiac monitoring devices and continuous advancements in remote monitoring technology are generating significant business opportunities for companies in the cardiovascular diagnostic and monitoring devices market
Feature | Implantable Cardiac Monitor (ICM)
Cardiovascular Diagnostic and Monitoring Devices Market to Cross $29B by 2031

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...

Home June 13, 2023
Home
Core Sound Imaging, Inc. has announced it will preview its new Studycast Integration Program during the 34th Annual Scientific Sessions of the American Society of Echocardiography (ASE2023), to be held June 23-26 in National Harbor, MD.
News | ASE
New Studycast Integration Program with AI Analysis for Echo Imaging to be Previewed at ASE 2023

June 13, 2023 — Core Sound Imaging, Inc. has announced the introduction of the Studycast Integration Program. The ...

Home June 13, 2023
Home
A representative case in which artificial intelligence–based quantitative coronary angiography (AI-QCA) showed a good correlation with intravascular ultrasound (IVUS) observation. %DS: percent diameter stenosis; DRD: distal reference diameter; LAD: left anterior descending artery; LCX: left circumflex artery; MLD: minimal luminal diameter; PRD: proximal reference diameter; RCA: right coronary artery; Ref.D: reference diameter.
News | Artificial Intelligence
Revolutionizing Cardiology: AI-Based Technology Offers Accurate Analysis of Cardiac Disease

June 12, 2023 — New research published in JMIR Cardio reveals the remarkable potential of artificial intelligence (AI) ...

Home June 12, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now